In this episode of The Peptide Effect Podcast, we break down Retatrutide, one of the most talked-about new research compounds in the weight loss and metabolic health world. We explain what Retatrutide is, why it’s called a “triple agonist,” and how it differs from Semaglutide and Tirzepatide. You’ll learn how it works on GLP-1, GIP, and glucagon receptors, what benefits researchers are seeing so far, and what side effects and risks people need to be aware of. If you’re curious about the future of fat loss peptides, insulin resistance support, and next-level metabolic compounds, this episode is a must-listen.

Disclaimer: This content is for educational purposes only and is not medical advice. Always consult a licensed healthcare provider before using any peptide or research compound.